Detalles de la búsqueda
1.
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Hematol Oncol
; 42(1): e3249, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287529
2.
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Br J Haematol
; 202(5): 928-936, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259629
3.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol
; 41(5): 877-883, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392141
4.
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
Ann Hematol
; 102(2): 385-392, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645458
5.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33378569
6.
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Am J Hematol
; 95(9): 1030-1037, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32419224
7.
Effects of Physical Exercise Intervention on Psychological and Physical Fitness in Lymphoma Patients.
Medicina (Kaunas)
; 55(7)2019 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31315290
8.
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Biol Blood Marrow Transplant
; 24(3): 608-613, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032271
9.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant
; 24(9): 1814-1822, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857196
10.
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
Ann Hematol
; 97(10): 1817-1824, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054707
11.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349541
12.
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
Am J Hematol
; 96(5): E168-E171, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580969
13.
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
Am J Hematol
; 96(8): E306-E310, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33989438
14.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Am J Hematol
; 96(8): E269-E272, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878220
15.
Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
Radiol Med
; 121(2): 132-43, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26349573
16.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Br J Haematol
; 185(5): 940-944, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407625
17.
Challenges and opportunities of microRNAs in lymphomas.
Molecules
; 19(9): 14723-81, 2014 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25232701
18.
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections.
Expert Rev Hematol
; 16(4): 267-276, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012253
19.
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study.
Viruses
; 15(5)2023 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243285
20.
Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.
Cancers (Basel)
; 14(3)2022 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158787